Profile for SPIKE-1: A Randomised Cycle II/III test inside a local community placing, evaluating usage of camostat in lessening the particular medical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane blend. (weekbanjo9)